Mina Jamzad | Neuropharmacology | Research Excellence Award

Published on by Neuroscientists

Assoc. Prof. Dr. Mina Jamzad | Neuropharmacology | Research Excellence Award

Assoc. Prof. Dr. Mina Jamzad | Islamic Azad University | Iran

Dr. Mina Jamzad is an Associated Professor of Organic Chemistry at the Qods Branch of the Islamic Azad University, where she has established a strong academic presence in natural products chemistry, phytochemistry, and the structural characterization of terpenoids and essential oils. She earned her PhD in Organic Chemistry from the Islamic Azad University, Science and Research Campus, where her research focused on the essential oil composition of selected Labiatae species and the extraction, isolation, purification, and structure elucidation of valuable terpenoids. Building on this foundation, she completed her master’s degree in Organic Chemistry at the university’s North Tehran Branch, conducting detailed studies on the essential oil profiles of Stachys pilifera and Salvia xanthochelea under the mentorship of Professor Abdolhossein Rustaiyan. Throughout her career, Dr. Jamzad has produced impactful research, contributing significantly to the understanding of aromatic plant chemistry and bioactive natural compounds. Her scholarly output includes numerous publications, collectively receiving 2,600 citations, supported by an h-index of 23 and an i10-index of 26, underscoring the scientific relevance and sustained influence of her work. Dedicated to both research and education, she continues to advance organic chemistry through rigorous scholarship and committed academic service.

Profile: Google Scholar

Featured Publications

Fakhari, S., Jamzad, M., & Kabiri Fard, H. (2019). Green synthesis of zinc oxide nanoparticles: A comparison. Green Chemistry Letters and Reviews, 12(1), 19–24.

Jamzad, M., & Kamari Bidkorpeh, M. (2020). Green synthesis of iron oxide nanoparticles by the aqueous extract of Laurus nobilis L. leaves and evaluation of the antimicrobial activity. Journal of Nanostructure in Chemistry, 10(3), 193–201.

Firoozi, S., Jamzad, M., & Yari, M. (2016). Biologically synthesized silver nanoparticles by aqueous extract of Satureja intermedia C.A. Mey and the evaluation of total phenolic and flavonoid contents and antioxidant activity. Journal of Nanostructure in Chemistry, 6(4), 357–364.

Masoudi, S., Jamzad, M., Attari, L., & Rustaiyan, A. (2003). Volatile constituents of Stachys pilifera Benth. and Stachys acerosa Boiss. from Iran. Journal of Essential Oil Research, 15(3), 189–190.

Rustaiyan, A., Jamzad, M., Masoudi, S., & Ameri, N. (2006). Volatile constituents of Nepeta heliotropifolia Lam., Mentha mozaffarianii Jamzad and Ziziphora persica Bunge: Three Labiatae herbs growing wild in Iran. Journal of Essential Oil Research, 18(3), 348–351.

Kashkouli, S., Jamzad, M., & Nouri, A. (2018). Total phenolic and flavonoids contents, radical scavenging activity and green synthesis of silver nanoparticles by Laurus nobilis L. leaves aqueous extract. Journal of Medicinal Plants and By-products, 7(1), 25–32.

Jamzad, M., Jamzad, Z., Mokhber, F., Ziareh, S., & Yari, M. (2013). Variation in essential oil composition of Mentha longifolia var. chlorodichtya Rech. f. and Ziziphora clinopodiodes Lam. growing in different habitats. Journal of Medicinal Plants Research, 7(22), 1618–1623.

Olfa Rebai | Neuropharmacology | Innovative Research Award

Published on by Neuroscientists

Dr. Olfa Rebai | Neuropharmacology | Innovative Research Award

Dr. Olfa Rebai is a neuroscientist and biological engineer specializing in neuroprotection, human nutrition, and bioactive natural compounds, with impactful research contributions reflected in  scientific publications, She serves as a university assistant and postdoctoral researcher at the University of Carthage, INSAT, within the Ecochimie Laboratory of the Department of Biological and Chemical Engineering. Her scientific work focuses on the antioxidant and neuroprotective properties of bioactive molecules extracted from Tunisian mulberry varieties Morus alba and Morus nigra, using advanced biochemical, physiological, and cellular models to elucidate their mechanisms of action. Dr. Rebai has extensive expertise across functional neurophysiology, cellular imaging, patch-clamp electrophysiology, ROS quantification, immunofluorescence, and Western blotting. Her academic background includes advanced training in biomolecules and functional regulation, biotechnology, and nutritional sciences, in addition to international research experience at leading neuroscience centers in Spain, including the University of the Basque Country and the Achucarro Basque Center for Neuroscience. She has taught human nutrition, food quality control, and biological sciences, while also contributing to national and international research collaborations. Dr. Rebai’s work advances innovative strategies for neuroprotection and the valorization of natural biomolecules.

Profile: Orcid

Featured Publication

Innovative vegan gummy candy based on carob syrup (Ceratonia siliqua L.): Nutritional, technological, and sensory evaluation.

Erfan Ghadirzadeh | Neuropharmacology | Young Researcher Award

Published on by Neuroscientists

Dr. Erfan Ghadirzadeh | Neuropharmacology | Young Researcher Award

Dr. Erfan Ghadirzadeh | Mazandaran University of Medical Sciences | Iran

Erfan Ghadirzadeh is a Postdoctoral Researcher at Mazandaran University of Medical Sciences, where he integrates clinical training as a Medical Doctor with a substantial record of scientific contributions in neurosciences, neurology, and public health. With more than 60 research documents, 395 citations, and an H-index of 11, he has developed a strong academic presence supported by extensive interdisciplinary work. His research encompasses experimental neuropharmacology, neuroendocrinology, behavioral neuroscience, and neuropsychiatry, including investigations of neuroprotective agents in models of stroke and traumatic brain injury, hormonal and behavioral mechanisms underlying neurological disorders, and molecular pathways influencing addiction-related behaviors. Dr. Ghadirzadeh has published 51 journal articles indexed in SCI and Scopus, authored 9 books, and holds editorial appointments with PLOS One, Axia Journal of Addiction Medicine and Therapeutic Science, and Deep Science Publishing. His scientific output is strengthened by institutional collaborations through the Non-Communicable Diseases Research Institute and the Student Research Committee at Mazandaran University of Medical Sciences, enabling engagement with large, multi-specialist research teams. With 60 completed or ongoing research projects, he continues to contribute significantly to experimental and translational neuroscience, advancing clinical knowledge and supporting the development of evidence-based medical practices.

Profiles : Google Scholar |  Orcid

Featured Publications

Rezaei, M., Rahmani, E., Khouzani, S. J., Rahmannia, M., Ghadirzadeh, E., et al. (2023). Role of artificial intelligence in the diagnosis and treatment of diseases (Vol. 3, Issue 1, pp. 1–160). Kindle.

Rahmani, E., Rezaei, M., Tavakoli, R., Ghadirzadeh, E., Sarnaghy, F. J., et al. (2023). Role of regenerative medicine in the treatment of diseases (Vol. 3, Issue 1, pp. 1–184). Kindle.

Poudineh, M., Poudineh, S., Hosseini, Z., Pouramini, S., Fard, S. S., Fadavian, H., et al. (2023). Risk factors for the development of cancers (Vol. 3, Issue 1, pp. 1–118). Kindle.

Farrokhi, M., Taheri, F., Moeini, A., Farrokhi, M., Khouzani, P. J., Ghadirzadeh, E., et al. (2024). Artificial intelligence for drug development, personalized prescriptions, and adverse event prediction (Vol. 4, Issue 1, pp. 1–180). Kindle.

Farrokhi, M., Taheri, F., Bayat, Z., Damiri, M., Farrokhi, M., Ghadirzadeh, E., et al. (2024). Role of lifestyle medicine in the prevention and treatment of diseases. Amazon Kindle Direct Publishing.

Karimian, S., Taheri, F., Farrokhi, M., Farrokhi, M., Bayat, Z., Zadeh, S. A. M., et al. (2024). Digital health and wearable technologies (Vol. 4, Issue 1, pp. 1–240). Kindle.

Farrokhi, M., Taheri, F., Farrokhi, M., Tosi, Y. E. K., Ghadirzadeh, E., Bagheri, M., et al. (2024). Nanomedicine: Technologies and applications (Vol. 4, Issue 1, pp. 1–196). Kindle.

Motavaselian, M., Farrokhi, M., Khouzani, P. J., Fard, A. M., Daeizadeh, F., et al. (2024). Diagnostic performance of ultrasonography for identification of small bowel obstruction: A systematic review and meta-analysis. Archives of Academic Emergency Medicine, 12(1), e33.

Fawad Ali Shah | Neuropharmacology |

Published on by Neuroscientists

Dr. Fawad Ali Shah | Neuropharmacology | Best Researcher Award

Dr. Fawad Ali Shah,  Prince Sattam bin Abdulaziz University, Saudi Arabia.

Dr. Fawad Ali Shah is an accomplished neuroscientist and pharmacologist whose academic journey began with a Pharm-D from the University of Malakand, Pakistan, and culminated in a Ph.D. in Neuroscience and Pharmacology from Gyeongsang National University, South Korea. With a strong foundation in neuroprotective pharmacology, his doctoral and postdoctoral research has focused on natural therapeutic agents for cerebral ischemia and brain injury. Professionally, he has held key academic roles in Pakistan, South Korea, Canada, and Saudi Arabia, currently serving as an Associate Professor at Prince Sattam Bin Abdulaziz University.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Fawad Ali Shah embarked on his academic journey with a profound interest in pharmaceutical sciences and neuroscience. He earned his Doctor of Pharmacy (Pharm-D) degree from the University of Malakand, Khyber Pakhtunkhwa, Pakistan, in 2010 with a First Division and a solid 70.88% score. His thesis, which explored ischemic and reperfusion injuries and their clinical implications, laid a strong foundation for his lifelong dedication to the neuropharmacological sciences. Driven by a deeper quest for knowledge, he pursued his Ph.D. at the esteemed Gyeongsang National University (GNU) in South Korea, where he specialized in neuroscience and pharmacology. Graduating with an A+ average in 2017, his doctoral research focused on investigating the neuroprotective effects of natural drug substances in models of cerebral ischemic injury. This blend of clinical insight and experimental pharmacology set the stage for his career in neuropharmacological research.

🧠 Professional Endeavors in Neuroscience

After earning his doctorate, Dr. Shah’s professional journey took a dynamic course across academia and clinical research institutions. He began as a Research Scholar and Lab Coordinator in the Neurobiology and Brain Histology Lab at GNU, deepening his technical expertise in neurohistology and preclinical pharmacology. Following this, he was appointed as Assistant Professor and then promoted to Associate Professor at Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad. His academic ascent continued with two prestigious postdoctoral positions: a lab-based postdoctoral fellowship at Robarts Research Institute, University of Western Ontario, Canada, and another at the University of Toronto. In 2022, he joined Prince Sattam Bin Abdulaziz University, Saudi Arabia, as an Associate Professor in the Department of Pharmacology and Toxicology. His teaching and mentorship roles have nurtured aspiring pharmacists and neuroscientists alike, while his hands-on work as a former Associate Pharmacist at GlaxoSmithKline (GSK) and Biogenics added vital industry experience to his academic pursuits.

🔬 Research Focus and Scientific Contributions

Dr. Shah’s research is anchored in the exploration of neuroprotective strategies, particularly involving natural drug substances in mitigating cerebral ischemia and related neuronal injuries. His scientific endeavors are characterized by a translational approach—bridging preclinical findings with potential therapeutic implications. Through a series of methodical investigations during his Ph.D. and postdoctoral tenures, he contributed to the understanding of ischemic brain injury mechanisms, drug-induced neuroprotection, and histopathological changes associated with brain trauma. He has significantly advanced the neuropharmacology discipline by contributing original research that addresses real-world health challenges, such as stroke and neurodegenerative conditions. His collaborations in Canadian research institutions have further enriched his methodological expertise and international research exposure.

📚 Teaching Excellence and Academic Impact

As a seasoned academic, Dr. Shah has been instrumental in delivering rigorous pharmacology and toxicology curricula to undergraduate and graduate pharmacy students. His dual role as a researcher and educator has empowered students with both theoretical understanding and laboratory proficiency. His mentorship extends beyond the classroom, guiding research projects and helping students build critical thinking in experimental neuroscience. His affiliation with academic institutions in Pakistan, South Korea, and Saudi Arabia demonstrates his global academic influence and his ability to adapt to diverse educational environments. His role in curriculum development and departmental leadership has contributed to the overall elevation of academic standards wherever he has served.

🏅 Recognition and Accolades

Dr. Fawad Ali Shah is an HEC (Higher Education Commission) Approved Supervisor, a recognition that attests to his academic merit and capability to guide M.Phil. and Ph.D. research. His scholarly distinction, demonstrated by first-class academic performance and international postdoctoral achievements, has earned him esteem in both academic and research circles. His involvement with reputed institutions like the University of Toronto and Robarts Research Institute has positioned him among globally recognized neuroscientists contributing to pharmacological innovation and brain research.

🌍 Global Reach and Influence

Dr. Shah’s academic and research footprints span several continents, including Asia, North America, and the Middle East. His international collaborations and transdisciplinary research have helped forge global scientific alliances. Through participation in international conferences, seminars, and research initiatives, he has disseminated key findings in neuropharmacology and inspired academic exchanges. His commitment to ethical and impactful research, along with his cross-border academic contributions, highlights his role as a globally engaged scholar advancing neuroscience for public health benefits.

🔮 Vision, Legacy, and Future Contributions

Looking ahead, Dr. Shah envisions expanding the therapeutic potential of natural compounds in managing neurodegenerative and cerebrovascular diseases. He aspires to establish advanced neuropharmacology labs in collaboration with global research centers to facilitate translational research and innovative drug discovery. His legacy lies in nurturing a new generation of neuroscientists, fostering research with clinical relevance, and strengthening the bridge between pharmaceutical education and neurological care. With a growing portfolio of impactful publications and international engagements, Dr. Shah is poised to remain a leading voice in neurotherapeutics and pharmacological innovation.

Publication

  1. Title: Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
    Author(s): Not listed
    Year: 2025
    Journal: Laboratory Animal Research

 

  1. Title: In Silico molecular docking and molecular dynamic simulation of transferrin coated Phenytoin loaded SLNs with molecular targets of epilepsy
    Author(s): Not listed
    Year: 2025
    Journal: PLOS ONE

 

  1. Title: Carvacrol attenuated myocardial infarction through NLRP3-mediated pyroptosis and mTOR/Nrf2/PPARγ-dependent autophagic signaling
    Author(s): Not listed
    Year: 2025
    Journal: Toxicology and Applied Pharmacology

 

  1. Title: Retraction notice to “Quercetin attenuated ischemic stroke induced neurodegeneration by modulating glutamatergic and synaptic signaling pathways”
    Author(s): Not listed
    Year: 2024
    Journal: Heliyon

 

  1. Title: Ghrelin’s modulation of growth hormone secretagogue receptors in primary glioblastoma and meningioma: A comprehensive in-vitro study
    Author(s): Not listed
    Year: 2025
    Journal: Biochemical and Biophysical Research Communications

 

  1. Title: Corrigendum to “pH-Sensitive Tacrolimus loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease”
    Author(s): Not listed
    Year: 2024
    Journal: European Journal of Pharmaceutics and Biopharmaceutics

 

  1. Title: Punicalagin improves inflammation and oxidative stress in rat model of pelvic inflammatory disease
    Author(s): Not listed
    Year: 2025
    Journal: Natural Product Research

 

  1. Title: Core-shell tablets designed for modified and sequential release of ibuprofen and rabeprazole
    Author(s): Not listed
    Year: 2024
    Journal: International Journal of Pharmaceutics

 

  1. Title: Effect of Bacillus clausii in attenuating symptoms of DSS-induced ulcerative colitis by modulating NFkB pathway and oxidative stress in mice
    Author(s): Not listed
    Year: 2024
    Journal: Clinical and Experimental Pharmacology and Physiology

 

  1. Title: Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy
    Author(s): Not listed
    Year: 2024
    Journal: AAPS PharmSciTech

 

🧾 Conclusion

Dr. Fawad Ali Shah stands out as a dedicated researcher, educator, and global academic contributor in the fields of neuroscience and pharmacology. His blend of international experience, pioneering research on natural neuroprotective agents, and commitment to academic excellence underscores his significant role in the advancement of neurotherapeutics. As he continues to inspire future scientists and lead innovative research, his impact will resonate across both the scientific and clinical communities, shaping the future of neurological health and pharmaceutical sciences.